These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1347947)

  • 1. Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses.
    Lupu R; Colomer R; Kannan B; Lippman ME
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2287-91. PubMed ID: 1347947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.
    Lupu R; Colomer R; Zugmaier G; Sarup J; Shepard M; Slamon D; Lippman ME
    Science; 1990 Sep; 249(4976):1552-5. PubMed ID: 2218496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of erbB-2 and its ligands in growth control of malignant breast epithelium.
    Lupu R; Dickson RB; Lippman ME
    Princess Takamatsu Symp; 1991; 22():49-60. PubMed ID: 1688228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP; Kokeny KE; Ridings JW; Dilts CA
    Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a novel growth factor from human breast cancer cells.
    Lupu R; Wellstein A; Sheridan J; Ennis BW; Zugmaier G; Katz D; Lippman ME; Dickson RB
    Biochemistry; 1992 Aug; 31(32):7330-40. PubMed ID: 1324710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of erbB-2 and its ligands in growth control of malignant breast epithelium.
    Lupu R; Dickson RB; Lippman ME
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):229-36. PubMed ID: 1356015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active c-erbB-2 induces short-term growth of FDC-P2 cells after IL-3 depletion.
    Wongsasant B; Matsuda S; Yamamoto T
    Biochem Biophys Res Commun; 1991 Dec; 181(3):981-8. PubMed ID: 1684897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation.
    Goldman R; Levy RB; Peles E; Yarden Y
    Biochemistry; 1990 Dec; 29(50):11024-8. PubMed ID: 1980216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.
    Kraus MH; Fedi P; Starks V; Muraro R; Aaronson SA
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2900-4. PubMed ID: 8464905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function.
    Humphrey PA; Gangarosa LM; Wong AJ; Archer GE; Lund-Johansen M; Bjerkvig R; Laerum OD; Friedman HS; Bigner DD
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1413-20. PubMed ID: 1678600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-erbB-2 promoter-specific DNA-binding protein isolated from human breast cancer tissues displays mitogenic activity.
    Sarkar FH; Smith MR; Hoover T; Princler G; Crissman JD; Visscher DW; Longo DL; Kung HF; Raziuddin
    J Biol Chem; 1994 Apr; 269(16):12285-9. PubMed ID: 7909319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells.
    Bacus SS; Huberman E; Chin D; Kiguchi K; Simpson S; Lippman M; Lupu R
    Cell Growth Differ; 1992 Jul; 3(7):401-11. PubMed ID: 1358180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB; Hynes NE; Lane HA
    Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
    Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase.
    Fazioli F; Bottaro DP; Minichiello L; Auricchio A; Wong WT; Segatto O; Di Fiore PP
    J Biol Chem; 1992 Mar; 267(8):5155-61. PubMed ID: 1347529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair.
    Arteaga CL; Winnier AR; Poirier MC; Lopez-Larraza DM; Shawver LK; Hurd SD; Stewart SJ
    Cancer Res; 1994 Jul; 54(14):3758-65. PubMed ID: 7913407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation.
    Samanta A; LeVea CM; Dougall WC; Qian X; Greene MI
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1711-5. PubMed ID: 7907421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.